Gabriele K.
- Country
- Germany
- Department
- Frauenklinik
Research Overview
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- Phase III Randomized, Double-Blind Trial of Atezolizumab with Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
- Phase III Randomized Trial of Palbociclib Plus Endocrine Therapy Versus Endocrine Therapy Alone in HR+/HER2- Early Breast Cancer
Data & Insights
Has run more than one trial at 61 of 307 partner sites.
Specializations
Breast Cancer Treatment Innovation
This investigator specializes in advancing treatment approaches for hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular emphasis on developing combination therapeutic strategies.
- Early-stage breast cancer interventions
- Endocrine therapy optimization
- Advanced breast cancer management
Their work explores novel therapeutic combinations including targeted therapies with standard endocrine treatments.
Therapeutic Response Analysis
The investigator focuses on comprehensive evaluation of treatment efficacy and resistance patterns in breast cancer, particularly in advanced disease settings.
- Progression-free survival assessment
- Overall survival monitoring
- Treatment resistance mechanisms
Their research encompasses spatial and temporal analysis of therapeutic responses in advanced breast cancer patients.
Immunotherapy Applications
The investigator studies innovative immunotherapeutic approaches in breast cancer treatment, with specific attention to triple-negative breast cancer interventions.
- Neoadjuvant therapy combinations
- Chemotherapy integration
- Event-free survival evaluation
Their work integrates immunotherapy with established chemotherapy protocols for enhanced treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.